Chatham Lodging Trust (CLDT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Voting matters and shareholder proposals
ISS recommended voting in line with the Board on all proposals except Proposal 4, which concerns amending the Equity Incentive Plan.
The Board strongly recommends a "FOR" vote on Proposal 4 to add 2,150,000 shares to the Equity Incentive Plan, representing about 4.20% of total shares and OP Units outstanding.
Without approval, the company would need to use less aligned and more costly compensation methods.
Executive compensation and say-on-pay
ISS recommended a "FOR" vote on the say-on-pay proposal, recognizing effective alignment of pay with long-term performance.
Over 95% of votes supported say-on-pay proposals in 2023 and 2024.
Majority of NEO compensation is equity-based, with 60% performance-based and subject to rigorous hurdles.
Clawback policy applies to both cash and equity awards; CEO has a 6x base salary share ownership guideline.
Board of directors and corporate governance
The Board of Trustees unanimously recommends approval of the amendment to the Equity Incentive Plan.
Latest events from Chatham Lodging Trust
- Industry-leading margins and RevPAR, strong balance sheet, and upside from tech market recovery.CLDT
Investor presentation2 Mar 2026 - Industry-leading margins, reduced leverage, and a return to profitability set the stage for 2026.CLDT
Q4 202527 Feb 2026 - Q2 RevPAR up 4%, Phoenix hotel acquired, and balance sheet strengthened despite higher costs.CLDT
Q2 20242 Feb 2026 - Q3 RevPAR growth, asset sales, and tech market strength support debt reduction and outperformance.CLDT
Q3 202416 Jan 2026 - Q4 RevPAR up 4%, margins expand, and leverage falls as tech markets drive growth.CLDT
Q4 202423 Dec 2025 - Proxy covers trustee elections, auditor ratification, executive pay, and equity plan amendment.CLDT
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor ratification, compensation, and plan amendment.CLDT
Proxy Filing2 Dec 2025 - Outperforming peers in RevPAR and margins, with strong growth potential from business travel recovery.CLDT
Investor Presentation27 Nov 2025 - Q2 2025 delivered resilient RevPAR, reduced leverage, and robust share repurchases.CLDT
Q2 202523 Nov 2025